Tenon Medical (NASDAQ:TNON – Get Free Report) and Positron (OTCMKTS:POSC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
Institutional & Insider Ownership
22.7% of Tenon Medical shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by insiders. Comparatively, 17.2% of Positron shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Tenon Medical and Positron’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tenon Medical | -396.26% | -409.04% | -114.60% |
| Positron | N/A | -311.50% | -89.54% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tenon Medical | $3.28 million | 2.27 | -$13.67 million | ($1.77) | -0.38 |
| Positron | $590,000.00 | 98.77 | -$2.39 million | ($0.12) | -14.83 |
Positron has lower revenue, but higher earnings than Tenon Medical. Positron is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current recommendations for Tenon Medical and Positron, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tenon Medical | 1 | 0 | 2 | 0 | 2.33 |
| Positron | 0 | 0 | 0 | 0 | 0.00 |
Tenon Medical currently has a consensus target price of $3.00, suggesting a potential upside of 346.96%. Given Tenon Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Tenon Medical is more favorable than Positron.
Volatility & Risk
Tenon Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Positron has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500.
About Tenon Medical
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
About Positron
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
